Pressor responses to brain dopaminergic stimulation

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 9-10, 1997, Pages 764-769

  Van Den Buuse, Maarten ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Baroreflex; Behaviour; Blood pressure; Dopamine; Hypertension; Mesolimbic; Quinpirole; Sympathetic; Vasopressin

Indexed keywords

CLONIDINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; QUINPIROLE; RILMENIDINE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYPERTENSION; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PRESSORECEPTOR REFLEX; RAT; VENTRAL TEGMENTUM;

EID: 0030979691     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02129.x     Document Type: Conference Paper

References (36)

1. 2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 1990; 10: 2587-600.
2. 3H]quinpirole binding sites in the rat brain. Synapse 1993; 14: 113-20.
3. Langer SZ, Vidal M, Duval N. Presynaptic dopamine receptors in the cardiovascular system. Clin. Exp. Hypertens 1987; A9: 837-51.
4. 2 receptor agonist, in the conscious rat. J. Pharmacol. Exp. Ther. 1986; 236: 735-42.
5. Van den Buuse M. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 1992; 262: 303-11.
6. Van den Buuse M. Effects of 7-hydroxy-N,N-di-n-propylaminotetralin on behaviour and blood pressure of spontaneously hypertensive rats. Eur. J. Pharmacol. 1993; 243: 169-77.
7. Van den Buuse M. Differential effects of quinelorane and pergolide on behaviour, blood pressure, and body temperature of spontaneously hypertensive rats and Wistar-Kyoto rats. Pharmacol. Biochem. Behav. 1995; 50: 389-97.
8. Van den Buuse M, Morton SJ, Cornish JL, Head GA. Prolonged effects of quinpirole on cardiovascular regulation. J. Pharmacol. Exp. Ther. 1996; 277: 473-83.
9. 3H]quinpirole. Eur. J. Pharmacol. 1991; 203: 105-9.
10. 2 receptors: Behavioral correlates. Neurosci. Lett. 1993; 161: 223-6.
11. 3 receptor antisense influences dopamine synthesis in rat brain. Neuroreport 1995; 6: 573-6.
12. 2 receptors in the posterior region of the nucleus tractus solitarius mediate the central pressor action of quinpirole (LY 171 555). Brain Res. Bull. 1990; 24: 97-103.
13. Lawrence AJ, Krstew E, Jarrott B. Functional dopamine D: receptors on rat vagal afferent neurones. Br. J. Pharmacol. 1995; 114: 1329-34.
14. 2 receptor agonist, lowers blood pressure in the conscious rat. Pharmacology 1987; 35: 194-202.
15. 2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats. J. Pharmacol. Exp. Ther. 1987; 242: 143-51.
16. Van den Buuse M. Pretreatment with quinpirole inhibits the central antihypertensive effects of rilmenidine and α-methyldopa in conscious rats. Eur. J. Pharmacol. 1997; 322: 191-9.
17. Spring A, Winkelmüller W. Ventral midbrain stimulation, blood pressure responses and their relation to the dopaminergic nigro-striatal pathways. Pflügers Arch. 1975; 358: 339-48.
18. Tan E, Goodchild AK, Dampney RAL. Intense vasoconstriction and bradycardia evoked by stimulation of neurons within the midbrain and ventral tegmentum of the rabbit. Clin. Exp. Pharmacol. Physiol. 1983; 10: 305-9.
19. Cornish JL, Van den Buuse M. Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system. Neurosci. Lett. 1994; 176: 142-6.
20. Cornish JL, Van den Buuse M. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin. Brain Res. 1995; 701: 28-38.
21. Cornish JL, Wilks DP, Van den Buuse M. A functional interaction between the brain mesolimbic dopaminergic system and vasopressin release in the regulation of blood pressure. Neuroscience 1997 (in press).
22. Lin MT, Tsay BL, Chen FF. Activation of dopaminergic receptors within the caudate-putamen complex facilitates reflex bradycardia in the rat. Jpn. J. Physiol. 1982; 32: 431-42.
23. Van den Buuse M, Versteeg DHG, De Jong W. Role of dopamine in the development of spontaneous hypertension. Hypertension 1984; 6: 899-905.
24. Van den Buuse M, Versteeg DHG, De Jong W. Brain noradrenaline and the development of hypertension: The effect of treatment with central 6-hydroxydopamine or DSP-4. Clin. Exp. Pharmacol. Physiol. 1986; 13: 469-76.
25. Van den Buuse M, Versteeg DHG, de Jong W. Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat. Brain Res. 1986; 368: 69-78.
26. Van den Buuse M, Jones CR, Wagner J. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats. Brain Res. Bull. 1992; 28: 289-97.
27. Van den Buuse M, De Boer S, Veldhuis HD, Versteeg DHG, De Jong W. Central 6-OHDA affects both open-field exploratory behaviour and the development of hypertension in SHR. Pharmacol. Biochem. Behav. 1986; 24: 15-21.
28. Van den Buuse M, Veldhuis HD, Versteeg DHG, de Jong W. Substantia nigra lesions attenuate the development of hypertension and behavioural hyperreactivity in spontaneously hypertensive rats. Pharmacol. Biochem. Behav. 1986; 25: 317-24.
29. 14C]acetylcholine release from nucleus caudatus slices: Differences between spontaneously hypertensive rats and Wistar-Kyoto rats. Brain Res. 1990; 509: 266-72.
30. 2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats. Eur. J. Pharmacol. 1991; 201: 125-33.
31. Van den Buuse M, de Jong W. Pharmacology of central dopaminergic modulation in hypertension. In: Saito H, Minami M, Parvez SH (eds). Progress in hypertension, vol. 2, Antihypertensive drugs today. VSP Press, Utrecht. 1992; 157-88.
32. 2 receptor mRNA levels are elevated in brain of young spontaneously hypertensive rats compared to age-matched Wistar-Kyoto rats. In: Ching MS, Widdop RE (eds). Proceedings of ASCEPT. Australasian Society of Clinical and Experimental Pharmacologists, Melbourne. 1996; 3: 42.
33. Goiny M, Lagercrantz H, Srinivasan M, Ungerstedt U, Yamamoto Y. Hypoxia-mediated in vivo release of dopamine in nucleus tractus solitarii of rabbits. J. Appl. Physiol. 1991; 70: 2395-400.
34. Van den Buuse M, De Jong W. Differential effects of dopaminergic drugs on open-field behaviour of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. J. Pharmacol. Exp. Ther. 1989; 248: 1189-96.
35. Ikeda M, Hirata Y, Fujita K et al. Effects of stress on release of dopamine and serotonin in the striatum of SHR: An in vivo voltametric study. Neurochem. Int. 1984; 6: 509-12.
36. Van den Buuse M, Versteeg DHG, De Jong W. Brain catecholamines and the development of hypertension in the spontaneously hypertensive rat. J. Hypertens. 1986; 4: 156-62.